Takayasu Arteritis in a 15-Year-Old Male Presenting with Constitutional Symptoms and Upper Limb Pulse Deficit: A Case Report a Resource-Limited Settings Authors: Hamda Abdirahman Mohamed, Nouh Ismail Botan, Sadam Ismail Ahmed, Mustafe Jamal Qawdhan Published: 2026 ABSTRACT AbstractBackgroundTakayasu arteritis (TA) is a chronic granulomatous large-vessel vasculitis that primarily affects the aorta and its major branches. It is rare in children and adolescents, often leading to diagnostic delays due to its nonspecific initial symptoms such as fever, fatigue, and arthralgia.Case PresentationWe report a 15-year-old male who presented with a several-month history of low-grade fever, easy fatigability, and progressive bilateral multiple joint pain. Notably, he had a history of BCG vaccination and no known tuberculosis exposure. Three weeks prior to diagnosis, he developed chest pain, vomiting, and significant weight loss. Physical examination was notable for absence of left radial and brachial pulses, The right arm blood pressure was 130/87 mmHg despite stable vital signs and unremarkable cardiac auscultation. Initial laboratory findings revealed normocytic anemia (hemoglobin 12 g/dL), elevated erythrocyte sedimentation rate (70 mm/hr), negative rheumatoid factor, and normal renal function. Echocardiography was normal. Computed tomography angiography (CTA) of the abdominal aorta demonstrated concentric arterial wall thickening of the superior mesenteric artery (SMA) with severe stenosis and collateral formation. CTA of the left upper limb revealed long-segment concentric thickening involving the left common carotid, subclavian, axillary, and proximal brachial arteries, Renal arteries were spared with focal occlusion of the brachial artery and distal collaterals. A diagnosis of Takayasu arteritis was made. The patient was initiated on prednisolone 60 mg daily (maximum dose) and methotrexate. Follow-up was arranged for one month.ConclusionThis case highlights a novel diagnostic pathway in a resource-limited setting, where a high index of clinical suspicion and meticulous physical examination—specifically bilateral pulse palpation—bridged the gap left by a lack of specialized rheumatology services. It demonstrates that even without advanced imaging like PET or MRA, timely diagnosis and intervention are possible in developing healthcare systems.Keywords: Takayasu arteritis, adolescent, vasculitis, pulselessness, CT angiography, case report Introduction Takayasu arteritis is a rare, chronic inflammatory arteriopathy of unknown etiology, predominantly affecting the aorta, its primary branches, and the pulmonary arteries. Takayasu arteritis (TA), also known as pulseless disease, is a chronic, idiopathic, granulomatous large-vessel vasculitis that primarily affects the aorta and its major branches, including the subclavian, carotid, and renal arteries.1 First described in 1908 by Dr. Mikito Takayasu, in the disease progresses from an early inflammatory phase to a late occlusive phase characterized by stenosis or aneurysms. The epidemiology of Takayasu arteritis shows significant geographic variation. It is most prevalent in Asia, India, Mexico, and South America, with an estimated annual incidence of 1–3 cases per million population.2 The disease is 8–10 times more common in females than males, with a peak age of onset between 10–40 years.3 Presentation in adolescent males, as in our case, is relatively uncommon, accounting for approximately 10–15% of pediatric cases.4 In the pediatric population, the EULAR/PRINTO/PRES 2010 (Ankara) criteria are the established framework for diagnosis, requiring large-vessel abnormalities on angiography (mandatory) plus one of the following: pulse deficit/claudication, blood pressure discrepancy, bruits, or hypertension. The clinical presentation of Takayasu arteritis is highly variable and depends on the stage and location of vascular involvement. The early “pre-pulseless” phase is characterized by nonspecific constitutional symptoms, including fever, malaise, weight loss, night sweats, arthralgia, and myalgia.5 These symptoms often lead to delayed diagnosis or misdiagnosis as infection, malignancy, or other connective tissue diseases.6 The late “occlusive” phase is characterized by vascular insufficiency symptoms, including pulselessness, blood pressure discrepancies, claudication, bruit, and symptoms of end-organ ischemia.7 The subclavian artery is the most commonly involved vessel, occurring in 60–90% of cases, leading to upper extremity pulse deficits—a finding that gave the disease its historical name “pulseless disease”.8 Diagnosis of Takayasu arteritis is based on a combination of clinical features, laboratory findings, and characteristic vascular imaging findings. The 1990 American College of Rheumatology (ACR) classification criteria require three or more of the following: age at onset <40 years, claudication of extremities, decreased brachial artery pulse, blood pressure difference >10 mmHg, bruit over subclavian or aorta, and arteriographic abnormality.1 In resource-limited settings such as Somaliland, diagnosis of Takayasu arteritis is particularly challenging due to limited access to vascular imaging, rheumatology services, and advanced laboratory testing.9 This case report describes a 15-year-old male with Takayasu arteritis presenting with absent left radial and brachial pulses, constitutional symptoms, and characteristic CT angiography findings. This case is reported in accordance with the SCARE 2025 guidelines.10 Prognosis has improved with earlier diagnosis and aggressive immunosuppression, but morbidity remains significant. Poor prognostic factors include progressive disease despite therapy, major complications (stroke, myocardial infarction, aortic regurgitation, aneurysm rupture), and delayed diagnosis. Case Presentation A Male 15-year-old previously healthy male presented with a several-month history of low-grade fever, easy fatigability, and progressive multiple joint pain (wrists, knees, ankles). He had been immunized with the BCG vaccine at birth and had no history of contact with tuberculosis patients. Three weeks before diagnosis, he developed intermittent non-exertional chest pain, vomiting, and unintentional weight loss. There was no history of rash, oral ulcers, photosensitivity, or prior COVID-19 infection. On admission, general appearance was stable Vital signs: temperature 36.9°C, pulse rate 100 beats/min, respiratory rate 20 breaths/min. Blood pressure in the right arm was 130/87 mmHg, which meets the criteria for Stage 1 hypertension for a 15-year-old (per AAP 2017 guidelines). Blood pressure was not obtainable from the left arm. Examination of all systems revealed: absence of left radial and brachial pulses (right side pulses normal); HEENT unremarkable; no lymphadenopathy; chest clear with symmetrical movement and normal breath sounds; heart sounds S1 and S2 normal, no murmurs, rubs, or gallop; abdomen soft, non-tender, no organomegaly; central nervous system intact. There were no bruits over the neck or abdomen. Investigations CBC: WBC 10,000/μL (neutrophils 40%, lymphocytes 60%), hemoglobin 12 g/dL, MCV 80 fL, platelets 230,000/μL. CBC: WBC 10,000/μL (neutrophils 40%, lymphocytes 60%), hemoglobin 12 g/dL, MCV 80 fL, platelets 230,000/μL. Inflammatory markers: ESR 70 mm/hr. (CRP was not available). Inflammatory markers: ESR 70 mm/hr. (CRP was not available). Imaging: Echocardiography was normal. Imaging: Echocardiography was normal. Rheumatology: Rheumatoid factor negative. Rheumatology: Rheumatoid factor negative. CT angiography (Abdomen): Concentric arterial wall thickening involving the superior mesenteric artery (SMA) with severe stenosis and prominent collaterals. CT angiography (Abdomen): Concentric arterial wall thickening involving the superior mesenteric artery (SMA) with severe stenosis and prominent collaterals. CT angiography (Chest and Neck): Imaging demonstrated long-segment concentric arterial wall thickening involving the thoracic aorta, the root of the left common carotid artery, and the left subclavian artery (Figure 1A and B). CT angiography (Chest and Neck): Imaging demonstrated long-segment concentric arterial wall thickening involving the thoracic aorta, the root of the left common carotid artery, and the left subclavian artery (Figure 1A and B). CT angiography (Upper Limb): Further evaluation revealed concentric arterial wall thickening of the left axillary artery and mural thickening of the proximal left brachial artery, associated with moderate luminal stenosis and focal occlusion (Figure 2A and B). CT angiography (Upper Limb): Further evaluation revealed concentric arterial wall thickening of the left axillary artery and mural thickening of the proximal left brachial artery, associated with moderate luminal stenosis and focal occlusion (Figure 2A and B). Renal function: Creatinine 0.8 mg/dL, BUN 30 mg/dL. Renal function: Creatinine 0.8 mg/dL, BUN 30 mg/dL. Diagnosis: Takayasu arteritis (Type I + IIb involvement according to Numano classification). Diagnosis: Takayasu arteritis (Type I + IIb involvement according to Numano classification). (A and B) CT angiography demonstrating long-segment concentric arterial wall thickening involving the thoracic aorta the root of the left common carotid artery, left subclavian artery(arrows) consistent with large-vessel vasculitis. (A and B) Concentric arterial wall thickening left axillary artery with mural thickening of the proximal left brachial artery associated with moderate luminal stenosis and focal occlusion (arrows). Findings are in keeping with Takayasu arteritis. Physical Examination On presentation, the patient appeared clinically stable and was conscious, alert, and oriented to time, place, and person. He looked chronically ill with noticeable weight loss and easy fatigability; however, he was not in acute distress. His vital signs were within acceptable ranges for age, with a body temperature of 36.9°C, pulse rate of 100 beats per minute, and respiratory rate of 20 breaths per minute. Blood pressure measurement was difficult on the left upper limb because of absent peripheral pulses thus we try to measure for Blood pressure finally (the left Arm was undetectable but right arm was 130/87 MMHG). Vascular examination revealed absent left radial and brachial pulses, suggesting significant arterial insufficiency involving the major branches of the aortic arch. The right upper limb pulses were palpable. No radio-radial delay was appreciated on the contralateral side. Capillary refill was preserved, and there were no signs of digital ischemia or gangrene. General physical examination showed no pallor, jaundice, cyanosis, clubbing, or peripheral edema. There was no palpable lymphadenopathy in the cervical, axillary, or inguinal regions. Nutritional assessment suggested mild wasting consistent with chronic inflammatory illness and recent weight loss. Head, eyes, ears, nose, and throat (HEENT) examination was unremarkable. There was no oral ulceration, conjunctival pallor, scleral icterus, or facial asymmetry. Neck examination did not reveal thyromegaly or jugular venous distension. No carotid bruit was appreciated on auscultation. Respiratory system examination revealed symmetrical chest expansion with normal respiratory effort. There was no use of accessory muscles of respiration or evidence of respiratory distress. Trachea was centrally located. Percussion notes were resonant throughout both lung fields, and auscultation demonstrated normal vesicular breath sounds bilaterally without wheezes, crackles, or rhonchi. Cardiovascular examination showed normal first and second heart sounds (S1 and S2) with regular rhythm and normal intensity. No murmurs, gallops, rubs, or additional heart sounds were heard. There was no clinical evidence of heart failure such as pedal edema, raised jugular venous pressure, or hepatomegaly. Peripheral vascular examination was significant for pulse asymmetry and absent pulses over the left upper limb, supporting the suspicion of large-vessel vasculitis. Abdominal examination was essentially normal. The abdomen was soft, non-tender, and non-distended, with no palpable masses or organomegaly. Bowel sounds were normal. There was no abdominal bruit appreciated on auscultation despite mesenteric vascular involvement demonstrated on imaging. Musculoskeletal examination revealed multiple joint pains without obvious joint swelling, redness, or deformity. There was no limitation of movement or evidence of active synovitis at the time of examination. Neurological examination demonstrated intact higher mental functions with preserved motor and sensory systems. Cranial nerves were grossly intact, muscle tone and power were normal in all extremities, and deep tendon reflexes were preserved. No focal neurological deficits or signs of raised intracranial pressure were identified. Treatment of Takayasu Arteritis Corticosteroids (First-Line Therapy): Prednisolone/prednisone 40–60 mg daily or 1 mg/kg/day (maximum 60 mg). Clinical response expected within 2–4 weeks. Steroid-Sparing Agents: Methotrexate (15–25 mg weekly), azathioprine (2–3 mg/kg/day), or mycophenolate mofetil (1–2 g daily). Biologic Therapy (for refractory disease): Tocilizumab (anti-IL-6) or TNF inhibitors (infliximab). Therapeutic Intervention The patient was started on Prednisolone 60 mg orally once daily and Methotrexate 15 mg orally once weekly with folic acid. Follow-up was scheduled for one month. Discussion This case illustrates the diagnostic challenge of Takayasu arteritis in an adolescent male. The prolonged course of low-grade fever, fatigue, arthralgia, weight loss, and eventual chest pain is consistent with the pre-pulseless (inflammatory) phase of TA, which can last weeks to months.5 However, EULAR/PRINTO/PRES 2010 criteria, the absence of left upper limb pulses at presentation already indicated chronic stenotic-occlusive changes, underscoring that silent vascular damage can occur before overt ischemic symptoms.7 The normal cardiac examination and echocardiography helped exclude congenital heart disease or subacute bacterial endocarditis. The absence of a murmur or bruits did not rule out large-vessel vasculitis.8 Notably, the patient did not have hypertension, a common finding in pediatric TA with renal artery involvement, but his normal blood pressure in the right arm did not preclude left subclavian stenosis.2 CT angiography was the key diagnostic modality, confirming characteristic concentric wall thickening and stenosis of multiple aortic arch branches and the superior mesenteric artery (SMA)11. While the SMA stenosis and collaterals offer a plausible hypothesis for the patient’s episodic vomiting (abdominal angina), it is important to note that he did not report classic postprandial pain.2 The focal brachial artery occlusion with distal collaterals explained the pulse loss.8 Regarding management, current 2018 EULAR recommendations suggest high-dose glucocorticoids (1–2 mg/kg/day)12 as first-line therapy. Steroid-sparing agents like methotrexate (15–25 mg weekly), azathioprine, or mycophenolate mofetil are added to maintain remission. In refractory cases, biologic therapies such as Tocilizumab (anti-IL-6) or TNF inhibitors (Infliximab) may be required. Diagnosing TA in a developing country like Somaliland presents unique hurdles. The lack of PET-CT or Magnetic Resonance Angiography (MRA)—standard in higher-resource settings for monitoring vessel wall inflammation—means clinicians must rely heavily on serial ESR measurements and clinical exams. Furthermore, the high prevalence of tuberculosis in the region often complicates the diagnosis of granulomatous vasculitis; however, our patient’s negative exposure history and previous BCG vaccination helped steer the diagnosis toward TA. Our patient received prednisolone 60 mg daily, the maximum standard initial dose in adolescents.12 Methotrexate was added as a steroid-sparing agent given the widespread arterial involvement.13 Close monitoring at one month will assess clinical response (return of pulses, resolution of systemic symptoms) and normalization of ESR.6 Limitations This report is limited by the absence of histological confirmation and the lack of CRP testing due to local resource constraints. Furthermore, advanced imaging (MRA/PET) to precisely assess disease activity was unavailable. Finally, as this is a recent diagnosis, long-term follow-up data to assess the clinical outcome and return of pulses are currently missing. Learning Points for Clinicians Always palpate bilateral brachial and radial pulses in any child or adolescent with unexplained fever, weight loss, or arthralgia. Always palpate bilateral brachial and radial pulses in any child or adolescent with unexplained fever, weight loss, or arthralgia. A normal ESR does not exclude TA, but a markedly elevated ESR (70 mm/hr) in this context is highly suspicious. A normal ESR does not exclude TA, but a markedly elevated ESR (70 mm/hr) in this context is highly suspicious. CT angiography is superior to echocardiography for detecting proximal great vessel involvement. CT angiography is superior to echocardiography for detecting proximal great vessel involvement. Early immunosuppression may prevent progression to irreversible arterial occlusion and limb or visceral ischemia. Early immunosuppression may prevent progression to irreversible arterial occlusion and limb or visceral ischemia. Conclusion Takayasu arteritis, although rare, should be considered in the differential diagnosis of adolescents presenting with constitutional symptoms (fever, fatigue, weight loss, arthralgia) and pulse deficits, even In resource-limited settings, clinicians must maintain a high index of suspicion, perform thorough bilateral vascular examinations, and utilize CTA when accessible to prevent devastating complications. Patient Perspective The patient and his family expressed significant concern about his prolonged illness (several months of symptoms) and the absence of a clear diagnosis. They reported relief when the diagnosis was finally established and expressed hope that treatment would improve his condition. They were counseled about the chronic nature of the disease, the need for long-term medication, and the importance of follow-up. Ethical Approval In our institute, the ethical approval is not required for publication of case reports, so our hospital is waived for case reports. Consent for Publication Written informed consent was obtained from the Patient and his Primary care giver (parent) for publication of this case report and accompanying images. Author Contributions All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work. Disclosure The authors report no conflicts of interest. References